{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:12:45Z","timestamp":1716376365058},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T00:00:00Z","timestamp":1241308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s10549-009-0403-4","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T20:29:01Z","timestamp":1241468941000},"page":"401-408","source":"Crossref","is-referenced-by-count":17,"title":["The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells"],"prefix":"10.1007","volume":"120","author":[{"given":"Arend","family":"Brinkman","sequence":"first","affiliation":[]},{"given":"Danielle","family":"de Jong","sequence":"additional","affiliation":[]},{"given":"Sietske","family":"Tuinman","sequence":"additional","affiliation":[]},{"given":"Najat","family":"Azaouagh","sequence":"additional","affiliation":[]},{"given":"Ton","family":"van Agthoven","sequence":"additional","affiliation":[]},{"given":"Lambert C. J.","family":"Dorssers","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,5,3]]},"reference":[{"key":"403_CR1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Group Early Breast Cancer Trialists\u2019 Collaborative (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"key":"403_CR2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.1995.13.2.513","volume":"13","author":"IA Jaiyesimi","year":"1995","unstructured":"Jaiyesimi IA, Buzdar AU, Decker DA et al (1995) Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 13:513\u2013529","journal-title":"J Clin Oncol"},{"key":"403_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrc721","volume":"2","author":"S Ali","year":"2002","unstructured":"Ali S, Coombes RC (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2:101\u2013112","journal-title":"Nat Rev Cancer"},{"key":"403_CR4","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/sj.onc.1206937","volume":"22","author":"R Clarke","year":"2003","unstructured":"Clarke R, Liu MC, Bouker KB et al (2003) Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22:7316\u20137339","journal-title":"Oncogene"},{"key":"403_CR5","doi-asserted-by":"crossref","first-page":"865s","DOI":"10.1158\/1078-0432.865s.11.2","volume":"11","author":"CK Osborne","year":"2005","unstructured":"Osborne CK, Shou J, Massarweh S et al (2005) Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 11:865s\u2013870s","journal-title":"Clin Cancer Res"},{"key":"403_CR6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mrfmmm.2005.02.028","volume":"591","author":"JS Lewis","year":"2005","unstructured":"Lewis JS, Jordan VC (2005) Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutat Res 591:247\u2013263","journal-title":"Mutat Res"},{"key":"403_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2007.03.016","volume":"256","author":"RB Riggins","year":"2007","unstructured":"Riggins RB, Schrecengost RS, Guerrero MS et al (2007) Pathways to tamoxifen resistance. Cancer Lett 256:1\u201324","journal-title":"Cancer Lett"},{"key":"403_CR8","first-page":"870","volume":"7","author":"LCJ Dorssers","year":"1993","unstructured":"Dorssers LCJ, Van Agthoven T, Dekker A et al (1993) Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site. Mol Endocrinol 7:870\u2013878","journal-title":"Mol Endocrinol"},{"key":"403_CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10549-008-9969-5","volume":"114","author":"T Agthoven Van","year":"2009","unstructured":"Van Agthoven T, Veldscholte J, Smid M et al (2009) Functional screen identifies genes associated with human breast cancer progression. Breast Cancer Res Treat 114:23\u201330","journal-title":"Breast Cancer Res Treat"},{"key":"403_CR10","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1002\/j.1460-2075.1994.tb06684.x","volume":"13","author":"R Sakai","year":"1994","unstructured":"Sakai R, Iwamatsu A, Hirano N et al (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation- dependent manner. EMBO J 13:3748\u20133756","journal-title":"EMBO J"},{"key":"403_CR11","doi-asserted-by":"crossref","first-page":"32740","DOI":"10.1016\/S0021-9258(20)30053-3","volume":"269","author":"R Sakai","year":"1994","unstructured":"Sakai R, Iwamatsu A, Hirano N et al (1994) Characterization, partial purification, and peptide sequencing of p130, the main phosphoprotein associated with v-Crk oncoprotein. J Biol Chem 269:32740\u201332746","journal-title":"J Biol Chem"},{"key":"403_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jnci\/92.2.112","volume":"92","author":"A Brinkman","year":"2000","unstructured":"Brinkman A, Van der Flier S, Kok EM et al (2000) BCAR1, a human homologue of the adapter protein p130Cas and antiestrogen resistance in breast cancer cells. J Natl Cancer Inst 92:112\u2013120","journal-title":"J Natl Cancer Inst"},{"key":"403_CR13","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1158\/0008-5472.CAN-08-2426","volume":"68","author":"HQ Ta","year":"2008","unstructured":"Ta HQ, Thomas KS, Schrecengost RS et al (2008) A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells. Cancer Res 68:8796\u20138804","journal-title":"Cancer Res"},{"key":"403_CR14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jnci\/92.2.120","volume":"92","author":"S Flier Van der","year":"2000","unstructured":"Van der Flier S, Brinkman A, Look MP et al (2000) Bcar1\/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. J Natl Cancer Inst 92:120\u2013127","journal-title":"J Natl Cancer Inst"},{"key":"403_CR15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/172460080101600303","volume":"16","author":"S Flier Van der","year":"2001","unstructured":"Van der Flier S, Van der Kwast TH, Claassen CJC et al (2001) Immunohistochemical study of the BCAR1\/p130Cas protein in non-malignant and malignant human breast tissue. Int J Biol Markers 16:172\u2013178","journal-title":"Int J Biol Markers"},{"key":"403_CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/1097-0215(20000920)89:5<465::AID-IJC11>3.0.CO;2-O","volume":"89","author":"S Flier Van der","year":"2000","unstructured":"Van der Flier S, Chan CMW, Brinkman A et al (2000) BCAR1\/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas. Int J Cancer 89:465\u2013468","journal-title":"Int J Cancer"},{"key":"403_CR17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1373\/clinchem.2003.029868","volume":"50","author":"N Grebenchtchikov","year":"2004","unstructured":"Grebenchtchikov N, Brinkman A, Van Broekhoven SPJ et al (2004) Development of an ELISA for measurement of BCAR1 protein in human breast cancer tissue. Clin Chem 50:1356\u20131363","journal-title":"Clin Chem"},{"key":"403_CR18","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1158\/1078-0432.CCR-04-0444","volume":"10","author":"LCJ Dorssers","year":"2004","unstructured":"Dorssers LCJ, Grebenchtchikov N, Brinkman A et al (2004) The prognostic value of BCAR1 in patients with primary breast cancer. Clin Cancer Res 10:6194\u20136202","journal-title":"Clin Cancer Res"},{"key":"403_CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0962-8924(99)01714-6","volume":"10","author":"GM O\u2019Neill","year":"2000","unstructured":"O\u2019Neill GM, Fashena SJ, Golemis EA (2000) Integrin signalling: a new cas(t) of characters enters the stage. Trends Cell Biol 10:111\u2013119","journal-title":"Trends Cell Biol"},{"key":"403_CR20","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1038\/sj.onc.1204785","volume":"20","author":"AH Bouton","year":"2001","unstructured":"Bouton AH, Riggins RB, Bruce-Staskal PJ (2001) Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 20:6448\u20136458","journal-title":"Oncogene"},{"key":"403_CR21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1091\/mbc.e07-09-0953","volume":"19","author":"MK Singh","year":"2008","unstructured":"Singh MK, Dadke D, Nicolas E et al (2008) A novel Cas family member, HEPL, regulates FAK and cell spreading. Mol Biol Cell 19:1627\u20131636","journal-title":"Mol Biol Cell"},{"key":"403_CR22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1242\/jcs.01025","volume":"117","author":"S Cabodi","year":"2004","unstructured":"Cabodi S, Moro L, Baj G et al (2004) p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J Cell Sci 117:1603\u20131611","journal-title":"J Cell Sci"},{"key":"403_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcb.2006.03.003","volume":"16","author":"P Defilippi","year":"2006","unstructured":"Defilippi P, Di Stefano P, Cabodi S (2006) p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16:257\u2013263","journal-title":"Trends Cell Biol"},{"key":"403_CR24","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1158\/0008-5472.CAN-05-3952","volume":"66","author":"RB Riggins","year":"2006","unstructured":"Riggins RB, Thomas KS, Ta HQ et al (2006) Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res 66:7007\u20137015","journal-title":"Cancer Res"},{"key":"403_CR25","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1158\/0008-5472.CAN-05-2909","volume":"66","author":"S Cabodi","year":"2006","unstructured":"Cabodi S, Tinnirello A, Di Stefano P et al (2006) p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 66:4672\u20134680","journal-title":"Cancer Res"},{"key":"403_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/1246","volume":"19","author":"H Honda","year":"1998","unstructured":"Honda H, Oda H, Nakamoto T et al (1998) Cardiovascular anomaly, impaired actin bundling and resistance to Src- induced transformation in mice lacking p130Cas. Nat Genet 19:361\u2013365","journal-title":"Nat Genet"},{"key":"403_CR27","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","volume":"125","author":"M Kim","year":"2006","unstructured":"Kim M, Gans JD, Nogueira C et al (2006) Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125:1269\u20131281","journal-title":"Cell"},{"key":"403_CR28","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1158\/0008-5472.CAN-07-1328","volume":"67","author":"GM O\u2019Neill","year":"2007","unstructured":"O\u2019Neill GM, Seo S, Serebriiskii IG et al (2007) A new central scaffold for metastasis: parsing HEF1\/Cas-L\/NEDD9. Cancer Res 67:8975\u20138979","journal-title":"Cancer Res"},{"key":"403_CR29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12013-007-0036-3","volume":"48","author":"M Singh","year":"2007","unstructured":"Singh M, Cowell L, Seo S et al (2007) Molecular basis for HEF1\/NEDD9\/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochem Biophys 48:54\u201372","journal-title":"Cell Biochem Biophys"},{"key":"403_CR30","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1074\/jbc.271.15.8959","volume":"271","author":"T Nakamoto","year":"1996","unstructured":"Nakamoto T, Sakai R, Ozawa K et al (1996) Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase. J Biol Chem 271:8959\u20138965","journal-title":"J Biol Chem"},{"key":"403_CR31","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1128\/MCB.20.16.5865-5878.2000","volume":"20","author":"MR Burnham","year":"2000","unstructured":"Burnham MR, Bruce-Staskal PJ, Harte MT et al (2000) Regulation of c-SRC activity and function by the adapter protein CAS. Mol Cell Biol 20:5865\u20135878","journal-title":"Mol Cell Biol"},{"key":"403_CR32","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1128\/MCB.21.22.7641-7652.2001","volume":"21","author":"PJ Ruest","year":"2001","unstructured":"Ruest PJ, Shin NY, Polte TR et al (2001) Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src. Mol Cell Biol 21:7641\u20137652","journal-title":"Mol Cell Biol"},{"key":"403_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2121-9-50","volume":"9","author":"A Sharma","year":"2008","unstructured":"Sharma A, Mayer BJ (2008) Phosphorylation of p130Cas initiates Rac activation and membrane ruffling. BMC Cell Biol 9:50","journal-title":"BMC Cell Biol"},{"key":"403_CR34","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/0008-5472.CAN-05-3152","volume":"66","author":"Y Shen","year":"2006","unstructured":"Shen Y, Jia Z, Nagele RG et al (2006) SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res 66:1543\u20131552","journal-title":"Cancer Res"},{"key":"403_CR35","doi-asserted-by":"crossref","first-page":"18914","DOI":"10.1074\/jbc.M608980200","volume":"282","author":"Y Shen","year":"2007","unstructured":"Shen Y, Khusial PR, Li X et al (2007) SRC utilizes Cas to block gap junctional communication mediated by connexin43. J Biol Chem 282:18914\u201318921","journal-title":"J Biol Chem"},{"key":"403_CR36","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1074\/jbc.M602311200","volume":"281","author":"P Patwardhan","year":"2006","unstructured":"Patwardhan P, Shen Y, Goldberg GS et al (2006) Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth. J Biol Chem 281:20689\u201320697","journal-title":"J Biol Chem"},{"key":"403_CR37","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.4049\/jimmunol.163.4.2104","volume":"163","author":"D Cai","year":"1999","unstructured":"Cai D, Clayton LK, Smolyar A et al (1999) AND-34, a novel p130Cas-binding thymic stromal cell protein regulated by adhesion and inflammatory cytokines. J Immunol 163:2104\u20132112","journal-title":"J Immunol"},{"key":"403_CR38","first-page":"6802","volume":"63","author":"D Cai","year":"2003","unstructured":"Cai D, Iyer A, Felekkis KN et al (2003) AND-34\/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Res 63:6802\u20136808","journal-title":"Cancer Res"},{"key":"403_CR39","doi-asserted-by":"crossref","first-page":"30118","DOI":"10.1074\/jbc.M003074200","volume":"275","author":"T Gotoh","year":"2000","unstructured":"Gotoh T, Cai D, Tian X et al (2000) p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor. J Biol Chem 275:30118\u201330123","journal-title":"J Biol Chem"},{"key":"403_CR40","doi-asserted-by":"crossref","first-page":"28264","DOI":"10.1074\/jbc.M303535200","volume":"278","author":"RB Riggins","year":"2003","unstructured":"Riggins RB, Quilliam LA, Bouton AH (2003) Synergistic promotion of c-Src activation and cell migration by Cas and AND-34\/BCAR3. J Biol Chem 278:28264\u201328273","journal-title":"J Biol Chem"},{"key":"403_CR41","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1158\/0008-5472.CAN-06-3455","volume":"67","author":"RS Schrecengost","year":"2007","unstructured":"Schrecengost RS, Riggins RB, Thomas KS et al (2007) Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Res 67:6174\u20136182","journal-title":"Cancer Res"},{"key":"403_CR42","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/emboj\/17.10.2799","volume":"17","author":"T Agthoven Van","year":"1998","unstructured":"Van Agthoven T, Van Agthoven TLA, Dekker A et al (1998) Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J 17:2799\u20132808","journal-title":"EMBO J"},{"key":"403_CR43","first-page":"5082","volume":"52","author":"T Agthoven Van","year":"1992","unstructured":"Van Agthoven T, Van Agthoven TLA, Portengen H et al (1992) Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75\u20131 human breast cancer cells. Cancer Res 52:5082\u20135088","journal-title":"Cancer Res"},{"key":"403_CR44","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1128\/MCB.18.6.3540","volume":"18","author":"SF Law","year":"1998","unstructured":"Law SF, Zhang YZ, Klein-Szanto AJP et al (1998) Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments. Mol Cell Biol 18:3540\u20133551","journal-title":"Mol Cell Biol"},{"key":"403_CR45","first-page":"428","volume":"1","author":"RB Riggins","year":"2003","unstructured":"Riggins RB, DeBerry RM, Toosarvandani MD et al (2003) Src-Dependent Association of Cas and p85 Phosphatidylinositol 3\u2032-Kinase in v-crk-Transformed Cells. Mol Cancer Res 1:428\u2013437","journal-title":"Mol Cancer Res"},{"key":"403_CR46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/373573a0","volume":"373","author":"T Pawson","year":"1995","unstructured":"Pawson T (1995) Protein modules and signalling networks. Nature 373:573\u2013580","journal-title":"Nature"},{"key":"403_CR47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jmb.2008.12.010","volume":"386","author":"ML Garron","year":"2009","unstructured":"Garron ML, Arsenieva D, Zhong J et al (2009) Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in Anti-oestrogen resistance. J Mol Biol 386:190\u2013203","journal-title":"J Mol Biol"},{"key":"403_CR48","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1128\/MCB.16.7.3327","volume":"16","author":"SF Law","year":"1996","unstructured":"Law SF, Estojak J, Wang BL et al (1996) Human enhancer of filamentation 1, a novel p130 cas -like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol Cell Biol 16:3327\u20133337","journal-title":"Mol Cell Biol"},{"key":"403_CR49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2008.17.1462","volume":"27","author":"T Agthoven Van","year":"2009","unstructured":"Van Agthoven T, Sieuwerts AM, Meijer-Van Gelder ME et al (2009) Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. J Clin Oncol 27:542\u2013549","journal-title":"J Clin Oncol"},{"key":"403_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jmr.755","volume":"19","author":"F Nasertorabi","year":"2006","unstructured":"Nasertorabi F, Tars K, Becherer K et al (2006) Molecular basis for regulation of Src by the docking protein p130Cas. J Mol Recognit 19:30\u201338","journal-title":"J Mol Recognit"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0403-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0403-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:52:14Z","timestamp":1684975934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0403-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0403-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,3]]}}}